$ISR bottom Pr $1.38 called 3/18/14 $1.21 Is
Post# of 63828
Posted On: 10/07/2014 11:26:10 AM
$ISR bottom Pr $1.38
called 3/18/14 $1.21
Isoray Announces Early Success for Young Peruvian Girl Utilizing Cesium-131 in First Stereotactic Implant for Inoperable Brain Cancer
2014-10-07 08:07 ET - News Release
RICHLAND, WA(Eteligis Inc.)
Website
Shares Outstanding: 54.69M
Float: 54.01M
10-K 8/29/14
Summary
Headlines
Tuesday, October 7, 2014
Why IsoRay (ISR) Stock Is Surging Todayat TheStreet
8:17 am IsoRay announces early success for young Peruvian girl utilizing Cesium-131 in first Stereotactic implant for inoperable brain cancerBriefing.com
Isoray Announces Early Success for Young Peruvian Girl Utilizing Cesium-131 in First Stereotactic Implant for Inoperable Brain CancerMarketwired
Saturday, October 4, 2014
ISORAY, INC. FinancialsEDGAR Online Financials
Tuesday, September 30, 2014
IsoRay, Inc. Reports Fiscal Year 2014 ResultsMarketwired
ISORAY, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibitsEDGAR Online
Monday, September 29, 2014
ISORAY, INC. Files SEC form 10-K, Annual ReportEDGAR Online
Friday, September 19, 2014
Stocks Creating Buzz TodayAccesswire
Thursday, September 18, 2014
IsoRay Has Tremendous Potential Gaining More Published Peer ReviewsAccesswire
Tuesday, September 9, 2014
IsoRay's Cesium-131 Cancer Treatment Products and Methods to Be Featured in Oral Presentations by Industry Leaders During the American Society for Radiation Oncology Convention (ASTRO)Marketwired
Thursday, September 4, 2014
ISORAY, INC. Files SEC form 8-K, Entry into a Material Definitive AgreementEDGAR Online
Wednesday, August 20, 2014
Medical Device Stocks ReportAccesswire
Thursday, August 14, 2014
ISORAY, INC. Files SEC form 8-K, Change in Directors or Principal OfficersEDGAR Online
Thursday, August 7, 2014
ISORAY, INC. Files SEC form 8-K, Entry into a Material Definitive AgreementEDGAR Online
Tuesday, August 5, 2014
IsoRay Announces Positive Peer Review Of Cesium-131 In Treatment Of Metastatic Brain CancerBenzinga
IsoRay's Cesium-131 Isotope Produces Excellent Results in Treating Metastatic Brain Cancer as Published in the Journal of NeurosurgeryMarketwired
Wednesday, July 23, 2014
Top Biotechnology StocksAccesswire
Monday, July 14, 2014
Why IsoRay (ISR) Stock Is Spiking Todayat TheStreet
IsoRay Makes First Cesium-131 Delivery for Treatment of an Inoperable Brain Cancer Afflicting a Young Child in PeruMarketwired
Monday, June 30, 2014
IsoRay Announces Its Addition to the Russell Microcap IndexMarketwired
called 3/18/14 $1.21
Isoray Announces Early Success for Young Peruvian Girl Utilizing Cesium-131 in First Stereotactic Implant for Inoperable Brain Cancer
2014-10-07 08:07 ET - News Release
RICHLAND, WA(Eteligis Inc.)
Website
Shares Outstanding: 54.69M
Float: 54.01M
10-K 8/29/14
Summary
Headlines
Tuesday, October 7, 2014
Why IsoRay (ISR) Stock Is Surging Todayat TheStreet
8:17 am IsoRay announces early success for young Peruvian girl utilizing Cesium-131 in first Stereotactic implant for inoperable brain cancerBriefing.com
Isoray Announces Early Success for Young Peruvian Girl Utilizing Cesium-131 in First Stereotactic Implant for Inoperable Brain CancerMarketwired
Saturday, October 4, 2014
ISORAY, INC. FinancialsEDGAR Online Financials
Tuesday, September 30, 2014
IsoRay, Inc. Reports Fiscal Year 2014 ResultsMarketwired
ISORAY, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibitsEDGAR Online
Monday, September 29, 2014
ISORAY, INC. Files SEC form 10-K, Annual ReportEDGAR Online
Friday, September 19, 2014
Stocks Creating Buzz TodayAccesswire
Thursday, September 18, 2014
IsoRay Has Tremendous Potential Gaining More Published Peer ReviewsAccesswire
Tuesday, September 9, 2014
IsoRay's Cesium-131 Cancer Treatment Products and Methods to Be Featured in Oral Presentations by Industry Leaders During the American Society for Radiation Oncology Convention (ASTRO)Marketwired
Thursday, September 4, 2014
ISORAY, INC. Files SEC form 8-K, Entry into a Material Definitive AgreementEDGAR Online
Wednesday, August 20, 2014
Medical Device Stocks ReportAccesswire
Thursday, August 14, 2014
ISORAY, INC. Files SEC form 8-K, Change in Directors or Principal OfficersEDGAR Online
Thursday, August 7, 2014
ISORAY, INC. Files SEC form 8-K, Entry into a Material Definitive AgreementEDGAR Online
Tuesday, August 5, 2014
IsoRay Announces Positive Peer Review Of Cesium-131 In Treatment Of Metastatic Brain CancerBenzinga
IsoRay's Cesium-131 Isotope Produces Excellent Results in Treating Metastatic Brain Cancer as Published in the Journal of NeurosurgeryMarketwired
Wednesday, July 23, 2014
Top Biotechnology StocksAccesswire
Monday, July 14, 2014
Why IsoRay (ISR) Stock Is Spiking Todayat TheStreet
IsoRay Makes First Cesium-131 Delivery for Treatment of an Inoperable Brain Cancer Afflicting a Young Child in PeruMarketwired
Monday, June 30, 2014
IsoRay Announces Its Addition to the Russell Microcap IndexMarketwired
(0)
(0)